One of the world’s biggest trials of COVID-19 therapies released its long-awaited interim results yesterday—and they’re a letdown. None of the four treatments in the Solidarity trial, which enrolled more than 11,000 patients in 400 hospitals around the globe, increased survival—not even the much-touted antiviral drug remdesivir.  The results, announcedContinue Reading

Healthy young people might not get the coronavirus vaccine until 2022 as public health officials focus on immunizing the elderly and other vulnerable groups first, top officials from the World Health Organization said Wednesday. Researchers have been warning that production constraints and hoarding could limit SARS-CoV-2 vaccine supplies. This warningContinue Reading

Harvard Health reports on new research that is suggesting that there may be long-term neurologic consequences in those who survive COVID infections, including more than seven million Americans and another 27 million people worldwide. Particularly troubling is increasing evidence that there may be mild — but very real — brainContinue Reading

Scientific American writes about what can be done to counter the problem of COVID-19 misinformation. In the United States, misinformation spread by elements of the media, by public leaders and by individuals with large social media platforms has contributed to a disproportionately large share of COVID-19 burden: we house 4Continue Reading